-
1دورية أكاديمية
المؤلفون: Cohn, Allen Lee, Yoshino, Takayuki, Heinemann, Volker, Obermannova, Radka, Bodoky, Gyorgy, Prausova, Jana, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Garcia-Alfonso, Pilar, Portnoy, David C., Van Cutsem, Eric, Yamazaki, Kentaro, Clingan, Philip R., Polikoff, Jonathon, Lonardi, Sara, O'Brien, Lisa M., Gao, Ling, Yang, Ling, Ferry, David, Nasroulah, Federico, Tabernero, Josep
المساهمون: Cohn, Allen Lee Rocky Mt Canc Ctr, 1800 Williams St, Denver, CO 80218 USA, Yoshino, Takayuki Hosp East, Natl Canc Ctr, Chiba, Japan, Heinemann, Volker Ludwig Maximilians Univ Hosp Munich, Munich, Germany, Obermannova, Radka Masaryk Mem Canc Inst, Brno, Czech Republic, Bodoky, Gyorgy Szent Laszlo Hosp, Budapest, Hungary, Prausova, Jana Univ Hosp Motol, Prague, Czech Republic, Garcia-Carbonero, Rocio Hosp Virgen del Rocio, Seville, Spain, Ciuleanu, Tudor Inst Oncol Cluj Napoca, Cluj Napoca, Romania, Garcia-Alfonso, Pilar Hosp Gen Univ Gregorio Maranon, Madrid, Spain, Portnoy, David C. West Clin, Memphis, TN USA, Van Cutsem, Eric Univ Hosp Gasthuisberg, Louvain, Belgium, Yamazaki, Kentaro Shizuoka Canc Ctr, Shizuoka, Japan, Clingan, Philip R. Southern Med Day Care Ctr, Wollongong, NSW, Australia, Polikoff, Jonathon Kaiser Permanente San Diego, San Diego, CA USA, Lonardi, Sara IRCCS, IOV, Padua, Italy, O'Brien, Lisa M. Eli Lilly & Co, Indianapolis, IN 46285 USA, Gao, Ling Eli Lilly & Co, Bridgewater, NJ USA, Yang, Ling Eli Lilly & Co, Bridgewater, NJ USA, Ferry, David Eli Lilly & Co, Bridgewater, NJ USA, Nasroulah, Federico Eli Lilly & Co, Buenos Aires, DF, Argentina, Tabernero, Josep Vall dHebron Univ Hosp, Barcelona, Spain, Tabernero, Josep Inst Oncol VHIO, Barcelona, Spain, Eli Lilly
مصطلحات موضوعية: Ramucirumab, Exposure-response, Colorectal cancer, Second line, FOLFIRI, Iii randomized-trial, Monoclonal-antibody, 1st-line therapy, Gastric-cancer, Irinotecan, Bevacizumab, Fluorouracil, Leucovorin, Panitumumab
العلاقة: http://hdl.handle.net/10668/18626Test; https://link.springer.com/content/pdf/10.1007/s00280-017-3380-z.pdfTest; 408616700018
-
2دورية
المؤلفون: Huang, Jane E., Hart, Lowell, Polikoff, Jonathon, Langmuir, Virginia, Zhang, Fan, Fehrenbacher, Louis
المصدر: Blood; November 2004, Vol. 104 Issue: 11 p4615-4615, 1p
-
3
المؤلفون: Takayuki Yoshino, Ling Yang, Pilar García-Alfonso, Allen Lee Cohn, Philip Clingan, F. Nasroulah, Jonathon Polikoff, Volker Heinemann, Lisa O’Brien, Eric Van Cutsem, David Craig Portnoy, Kentaro Yamazaki, Jana Prausová, Rocio Garcia-Carbonero, Josep Tabernero, György Bodoky, Tudor Ciuleanu, Ling Gao, David Ferry, Sara Lonardi, Radka Obermannova
المساهمون: [Cohn, Allen Lee] Rocky Mt Canc Ctr, 1800 Williams St, Denver, CO 80218 USA, [Yoshino, Takayuki] Hosp East, Natl Canc Ctr, Chiba, Japan, [Heinemann, Volker] Ludwig Maximilians Univ Hosp Munich, Munich, Germany, [Obermannova, Radka] Masaryk Mem Canc Inst, Brno, Czech Republic, [Bodoky, Gyorgy] Szent Laszlo Hosp, Budapest, Hungary, [Prausova, Jana] Univ Hosp Motol, Prague, Czech Republic, [Garcia-Carbonero, Rocio] Hosp Virgen del Rocio, Seville, Spain, [Ciuleanu, Tudor] Inst Oncol Cluj Napoca, Cluj Napoca, Romania, [Garcia-Alfonso, Pilar] Hosp Gen Univ Gregorio Maranon, Madrid, Spain, [Portnoy, David C.] West Clin, Memphis, TN USA, [Van Cutsem, Eric] Univ Hosp Gasthuisberg, Louvain, Belgium, [Yamazaki, Kentaro] Shizuoka Canc Ctr, Shizuoka, Japan, [Clingan, Philip R.] Southern Med Day Care Ctr, Wollongong, NSW, Australia, [Polikoff, Jonathon] Kaiser Permanente San Diego, San Diego, CA USA, [Lonardi, Sara] IRCCS, IOV, Padua, Italy, [O'Brien, Lisa M.] Eli Lilly & Co, Indianapolis, IN 46285 USA, [Gao, Ling] Eli Lilly & Co, Bridgewater, NJ USA, [Yang, Ling] Eli Lilly & Co, Bridgewater, NJ USA, [Ferry, David] Eli Lilly & Co, Bridgewater, NJ USA, [Nasroulah, Federico] Eli Lilly & Co, Buenos Aires, DF, Argentina, [Tabernero, Josep] Vall dHebron Univ Hosp, Barcelona, Spain, [Tabernero, Josep] Inst Oncol VHIO, Barcelona, Spain, Eli Lilly
المصدر: Cancer Chemotherapy and Pharmacology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madridمصطلحات موضوعية: Oncology, Male, Cancer Research, Leucovorin, Toxicology, 030226 pharmacology & pharmacy, 0302 clinical medicine, Pharmacology (medical), education.field_of_study, Exposure-response, Panitumumab, Antibodies, Monoclonal, Exposure–response, Bevacizumab, Quartile, 030220 oncology & carcinogenesis, FOLFIRI, Original Article, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, medicine.medical_specialty, Population, Antineoplastic Agents, Neutropenia, Irinotecan, Antibodies, Monoclonal, Humanized, Ramucirumab, Disease-Free Survival, 03 medical and health sciences, Folinic acid, Internal medicine, medicine, Humans, education, Aged, Pharmacology, Second line, Proportional hazards model, business.industry, Iii randomized-trial, medicine.disease, Monoclonal-antibody, Colorectal cancer, digestive system diseases, Gastric-cancer, business, 1st-line therapy
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ae755a5849ab8f5cceec01e6bdf5deTest
http://europepmc.org/articles/PMC5573752Test